Marginum receives Export2X Internationalisation Award
Marginum has received the 2026 Export2X Internationalisation Award, recognising its rapid growth and expansion into global markets.
-
Marginum signs U.S. Distribution Agreement with ABS Med
ABS Med has partnered with Marginum to support the planned distribution of HIVEN® across key Midwestern U.S. states, subject to FDA authorisation.
Marginum HIVEN® wins Red Dot Product Design Award
Marginum wins the prestigious Red Dot Design Award for HIVEN® device, recognising its innovation in advancing cancer surgery through user-centred design.
Marginum Launches U.S. Clinical Trial with First Patient Treated
Marginum launches a U.S. clinical study with the HIVEN® device at the University of Illinois Hospital & Clinics (UI Health) in Chicago.
Strategic distribution partnership with ALMEDA
ALMEDA, a Prague-based medical equipment distributor, has partnered with Marginum to distribute its HIVEN® device in the Czech Republic and Slovakia.
First-in-Human Study: HIVEN® Performance and Safety Results
A first-in-human study shows that HIVEN®-based aspirate tissue monitoring provides nearly 5 times more fluorescence information than visual guidance alone.
Marginum CEO nominated for Pohjola Medical Innovation Award
CEO Samu Lehtonen has been nominated for the prestigious Pohjola Medical Innovation Award in recognition of the Marginum team’s scientific contributions.
Marginum awarded Young Innovative Companies (YIC) Funding
Marginum has been selected for the prestigious Young Innovative Companies (YIC) program, a recognition reserved for Finland’s most promising startups.
Marginum advances in U.S. Usability and Clinical Studies
Marginum has completed the HIVEN® usability assessment at the University of Illinois College of Medicine Surgical Innovation and Training Laboratory.
Strategic distribution partnership with Thomy F.E., d.o.o.
Thomy F.E., d.o.o., one of Slovenia’s leading distributors of advanced medical and surgical technologies, has formed a strategic partnership with Marginum.
Marginum is a medical technology company developing fluorescence-based tissue detection systems. We use data-driven solutions to improve surgical tissue monitoring.